Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2010
08/05/2010US20100197707 Platelet manipulation to reduce the incidence of and treat endovascular disease and its sequelae, to reduce the incidence of and treat arrhythmias and to reduce the incidence of malignancy
08/05/2010US20100197701 Method of treating diabetes
08/05/2010US20100197699 I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5) Decan-2-One Derivatives For The Treatment of Eating Disorders
08/05/2010US20100197692 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/05/2010US20100197691 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
08/05/2010US20100197684 Substituted heterocyclic compounds
08/05/2010US20100197683 Fused ring compound and use thereof
08/05/2010US20100197677 Oxadiazoanthracene compounds for the treatment of diabetes
08/05/2010US20100197675 Cyclic urea and carbamate inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
08/05/2010US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis
08/05/2010US20100197671 Phenyl amino pyrimidine compounds and uses thereof
08/05/2010US20100197668 1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYRROLO[1,2-a][1,4]-DIAZEPINE-7-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
08/05/2010US20100197662 Heterocyclic compound having type i 11 beta hydroxysteroid dehydrogenase inhibitory activity
08/05/2010US20100197658 Pharmaceutical use of fused 1,2,4-triazoles
08/05/2010US20100197657 2-aryl or heteroaryl indole derivatives
08/05/2010US20100197652 Pyridine carboxamide orexin receptor antagonists
08/05/2010US20100197625 Synthetic lipophilic inositol glycans for treatment of cancer and glucose-metabolism disorders
08/05/2010US20100197618 Extract of rehmannia glutinasa libosch for reducing blood sugar, reducing blood fat, treating leukemia, and preparation method uses thereof
08/05/2010US20100197617 Process for the preparation of caralluma extract and a formulation prepared thereof
08/05/2010US20100197609 Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
08/05/2010US20100197608 Use of melanotrophin-potentiating factor as a therapeutic agent
08/05/2010US20100197605 Therapeutic use of peptide yglf and combination with kvlpvpq
08/05/2010US20100197604 Use of peptide as a therapeutic agent
08/05/2010US20100197603 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections
08/05/2010US20100197601 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection
08/05/2010US20100197600 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh as a therapeutic agent
08/05/2010US20100197599 Use of a peptide as a therapeutic agent
08/05/2010US20100197596 Compositions and methods for diagnosis and treatment of type 2 diabetes
08/05/2010US20100197591 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES
08/05/2010US20100197590 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES
08/05/2010US20100197588 Use of a peptide as a therapeutic agent
08/05/2010US20100197587 Use of a peptide as a therapeutic agent
08/05/2010US20100197586 Use of secretin and optionally urodilatin as therapeutic agents
08/05/2010US20100197585 Use of a rgd-peptide and/or parathyroid hormone (1-34) as anti-hiv agent
08/05/2010US20100197584 Use of curcumin to block brain tumor formation in mice
08/05/2010US20100197572 Use of somatostatin-14 as a therapeutic agent
08/05/2010US20100197565 Dry powder drug delivery system
08/05/2010US20100197564 Diaryl morpholines as cb1 modulators
08/05/2010US20100197562 Functionally selective alpha2c adrenoreceptor agonists
08/05/2010US20100196497 Method of Treating Tissue Using Platelet-Rich Plasma in Combination with Low-Level Laser Therapy
08/05/2010US20100196496 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
08/05/2010US20100196488 Pharmaceutical Formulation
08/05/2010US20100196443 Use of cordyceps species or extract thereof in the egg production
08/05/2010US20100196439 Angiogenesis Mechanism and Method, and Implantable Device
08/05/2010US20100196433 Prevascularized devices and related methods
08/05/2010US20100196413 Use of Yeast Flakes for Treating and/or Preventing Hyperinsulinemia
08/05/2010US20100196405 GLP-1 Fc FUSION PROTEIN FORMULATION
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196396 Compositions and methods for modulating ghrelin-mediated conditions
08/05/2010US20100196359 Human Monoclonal Antibody Human CD134 (Ox40) and Methods of Making and Using Same
08/05/2010US20100196344 Compositions and methods for treating pancreatic insufficiency
08/05/2010US20100196330 Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
08/05/2010US20100196315 IL-12/p40 BINDING PROTEINS
08/05/2010US20100196305 Sulfone polymer compositions
08/05/2010DE102009007780A1 Pflanzen-Extrakte zur Regulation des Körpergewichtes Plant extracts for the regulation of body weight
08/05/2010DE102009006602A1 Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
08/05/2010CA2758599A1 Use of whole grain materials with high resistant starch for satiety, reduction of food intake and weight management
08/05/2010CA2751041A1 Prophylactic agent or therapeutic agent for disease resulting from abnormal bone metabolism
08/05/2010CA2750835A1 Carboxamide compounds and methods for using the same
08/05/2010CA2750801A1 Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
08/05/2010CA2750798A1 Dpp-iv inhibitors for treatment of diabetes in paediatric patients
08/05/2010CA2750769A1 Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
08/05/2010CA2750742A1 Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
08/05/2010CA2750685A1 Composition comprising chicoric acid and/or derivatives thereof
08/05/2010CA2750245A1 Polynucleotide aptamer-based cross-linked materials and uses thereof
08/05/2010CA2750086A1 Scriptaid isosteres and their use in therapy
08/04/2010EP2213750A1 Process for preparing docosahexaenoic acid and docosapentaenoic acid
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213675A1 Pyridooxazepine derivative and use thereof
08/04/2010EP2213291A1 Antisense inhibition of PTP1B expression
08/04/2010EP2213289A1 Combination treatment for diabetes mellitus
08/04/2010EP2213286A1 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes and cardiovascular diseases
08/04/2010EP2212314A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators
08/04/2010EP2212305A1 Beta-lactone compounds
08/04/2010EP2211893A2 Peptide compounds for treating obesity and insulin resistance
08/04/2010EP2211848A1 Trans-clomiphene for metabolic syndrome
08/04/2010EP2211639A2 Novel nacl salt substitute, use thereof and products containing same
08/04/2010EP2062598B1 Gel type enteric nutrient
08/04/2010EP1874737B1 Substituted 2-aminoalkylthio-benzimidazoles and use thereof for reducing blood sugar levels
08/04/2010EP1670744B1 4-((phenoxyalkyl)thio)-phenoxyacetic aci ds and analogs
08/04/2010EP1638947B1 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
08/04/2010EP1497262B1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
08/04/2010EP1429750B1 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
08/04/2010EP1343769B1 Benzoylpyridazines
08/04/2010CN1934122B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
08/04/2010CN101796053A Piperidine derivatives useful as orexin receptor antagonists
08/04/2010CN101796043A Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
08/04/2010CN101796033A Substituted piperazines as CB1 antagonists
08/04/2010CN101796032A Substituted piperazines as CB1 antagonists
08/04/2010CN101795704A Oral composition
08/04/2010CN101795698A Composition for prevention or treatment of disease associated with the production of autoantibody
08/04/2010CN101795678A Extracts with liver-X-receptor modulators, compounds and their use especially in weight control
08/04/2010CN101792750A Yolk antibody for resisting activity of alpha-glucosidase and antigen, preparation method and application thereof
08/04/2010CN101792440A Quinazolinone derivatives, preparation and application thereof
08/04/2010CN101792417A Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
08/04/2010CN101792415A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/04/2010CN101791383A Compound chicory series product and effect of adjusting blood sugar, blood fat and blood uric acid
08/04/2010CN101791369A Traditional Chinese medicine formula for delaying complications of diabetes
08/04/2010CN101791365A Discorea nipponica makino extractive and application thereof in preparing medicaments for resisting free radicals and reducing blood fat
08/04/2010CN101791359A Natural selenium-enriched green tea functional composite component extracting method
1 ... 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 ... 1298